Lonza has completed its planned cGMP clinical and commercial drug product manufacturing line in Visp (CH). The new line will support drug product manufacturing needs for both clinical and commercial supply. The 1,200 square meter cGMP facility includes a state-of-the-art liquid and lyophilized vial filling isolator line for multiple modalities that fulfils the GMP Annex 1 requirement for the manufacture of sterile products. The line is fully operational and cGMP licensed, with the first customer...